255
Views
6
CrossRef citations to date
0
Altmetric
Regular Articles

The scope of phytotherapy in southern African antidiabetic healthcare

, , , , &

REFERENCES

  • Abdel-Barry, J.A., Abdel-Hassan, I.A. & Al-Hakiem, M.H.H. 1997. Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum-graecum leaf in normal and alloxan induced diabetic rats. Journal of Ethnopharmacology 58: 149–155.
  • Adefuye, O.J. 2016. Anti-diabetic and phytochemical analysis of Sutherlandia frutescens extracts. Unpublished PhD thesis, Nelson Mandela Metropolitan University.
  • Adler, J.H., Lazarovici, G. & Marton, M.L.E. 1986. The diabetic response of weanling sand rats (Psammomys obesus) to diets containing different concentrations of salt bush (Atriplex halimus). Diabetes Research 3: 169–171.
  • Afolayan, A.J. & Sunmonu, T.O. 2010. In vivo studies on antidiabetic plants used in South African herbal medicine. Journal of Clinical Biochemistry and Nutrition 47: 98–106.
  • Afolayan, A.J. & Sunmonu, T.O. 2013. Evaluation of antidiabetic activity and associated toxicity of Artemisia afra aqueous extract in wistar rats. Evidence-Based Complementary and Alternative Medicine 2013: 929074.
  • Aguilar-Bryan, L., Nichols, C.G., Wechsler, S.W., Clement, J., Boyd, A., Gonzalez, G., Herrera-Sosa, H., Nguy, K., Bryan, J. & Nelson, D. 1995. Cloning the β cell high-affinity sulphonylurea receptor: a regulator of insulin secretion. Science 268: 423-426.
  • Aharonson, Z., Shani, J.J. & Sulman, F.G. 1969. Hypoglycaemic effect of the salt bush (Atriplex halimus) – a feeding source of the sand rat (Psammomys obesus). Diabetologia 5: 379–383.
  • Ahrén, B. 2013. GLP-1 receptor agonists in the treatment of Type 2 diabetes. Diabetes Management 3: 401–413.
  • Ahrén, B. & Foley, J.E. 2008. The islet enhancer vildagliptin: mechanisms of improved glucose metabolism. International Journal of Clinical Practice 159: 8–14.
  • Ajao, A.A. & Ashafa, A.O.T. 2017. Kinetics of inhibitory action of Myrothamnus flabellifolius Welw. on the activities of α-amylase and α-glucosidase. Comparative Clinical Pathology 26: 911–920.
  • Al-Shaqha, W.M., Khan, M., Salam, N., Azzi, A. & Chaudhary, A.A. 2015. Anti-diabetic potential of Catharanthus roseus Linn. and its effect on the glucose transport gene (GLUT-2 and GLUT-4) in streptozotocin induced diabetic wistar rats. BMC Complementary and Alternative Medicine 15. doi:10.1186/s12906-015-0899-6.
  • Anz, D., Kruger, S., Haubner, S., Rapp, M., Bourquin, C. & Endres, S. 2014. The dipeptidylpeptidase-IV inhibitors sitagliptin, vildagliptin and saxagliptin do not impair innate and adaptive immune responses. Diabetes, Obesity and Metabolism 16: 569–572.
  • Arnold, T.H., Prentice, C.A., Hawker, L.C., Snyman, E.E., Tomalin, M., Crouch, N.R. & Pottas-Bircher, C. 2002. Medicinal and magical plants of Southern Africa: An Annotated Checklist Strelitzia 13. Pretoria, National Botanical Institute.
  • Atta-Ur, R. & Zaman, K. 1989. Medicinal plants with hypoglycaemic activity. Journal of Ethnopharmacology 26: 1–55.
  • Bailey, C.J. 2003. New approaches to the pharmacotherapy of diabetes. In J.C. Pickup and G. William (Eds), Textbook of Diabetes, vol. 2, 3rd edn. Blackwell Science, pp. 1–73.
  • Baldeón, M.E., Castro, J., Villacrés, E., Narváez, L. & Fornasini, M. 2012. Hypoglycaemic effect of cooked Lupinus mutabilis and its purified alkaloids in subjects with type-2 diabetes. Nutrición Hospitalaria 27: 1261–1266.
  • Balogun, F.O. & Ashafa, A.O.T. 2018. Oxidative stress mitigation, kinetics of carbohydrate-enzymes inhibition and cytotoxic effects of flavonoids-rich leaf extract of Gazania krebsiana (Less.): An in vitro evaluation. Asian Pacific Journal of Tropical Biomedicine 8: 52–58.
  • Balogun, F.O., Tshabalala, N.T. & Ashafa, A.O.T. 2016. Antidiabetic medicinal plants used by the Basotho tribe of Eastern Free State: a review. Journal of Diabetes Research. doi:10.1155/2016/4602820.
  • Barnett, A. 2006. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. International Journal of Clinical Practice 60: 1454–1470.
  • Benzi, G., Villa, R.F., Dossena, M., Vercesi, L., Gorini, A. & Pastoris, O. 1984. Role of drugs in recovery of metabolic function of rat brain following severe hypoglycemia. Neurochemical Research 9: 979–992.
  • Beran, D., Yudkin, J.S. & De Courten, M. 2005. Access to care for patients with insulin-requiring diabetes in developing countries: Case studies of Mozambique and Zambia. Diabetes Care 28: 2136–2140.
  • Bertram, M., Jaswal, A.V., van wyk, V.P., Levitt, N.S. & Hofman, K.J. 2013. The non-fatal disease burden caused by type 2 diabetes in South Africa, 2009. Global Health Action doi:10.3402/gha.v6i0.19244.
  • Bharti, S.K., Krishnan, S., Kumar, A. & Kumar, A. 2018. Antidiabetic phytoconstituents and their mode of action on metabolic pathways. Therapeutic Advances in Endocrinology and Metabolism 9: 81–100.
  • Bhowmik, A., Khan, L.A., Akhter, M. & Rokeya, B. 2009. Studies on the antidiabetic effects of Mangifera indica stem-barks and leaves on nondiabetic, type 1 and type 2 diabetic model rats. Bangladesh Journal of Pharmacology 4(2): 110–114.
  • Blumer, I., Edelman, S.V. & Hirsch, I.B. 2012. Insulin-pump therapy for type 1 diabetes mellitus. The New England Journal of Medicine 367: 383–384.
  • Borges-De Melo, E., Da Silveira-Gomes, A. & Carvalho, I. 2006. α- and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 62: 10277–10302.
  • Cariou, B., Charbonnel, B. & Staels, B. 2012. Thiazolidinediones and PPARγ agonists: Time for a reassessment. Trends in Endocrinology and Metabolism 23: 205–215.
  • Chadwick, W.A., Roux, S., Van De Venter, M., Louw, J. & Oelofsen, W. 2007. Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet. Journal of Ethnopharmacology 109: 121–127.
  • Chiasson, J.L. 2006. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocrine Practice 12: 25–30.
  • Chikhi, I., Allali, H., El Amine D, M., Medjdoub, H. & Tabti, B. 2014. Antidiabetic activity of aqueous leaf extract of Atriplex halimus L. (Chenopodiaceae) in streptozotocin-induced diabetic rats. Asian Pacific Journal of Tropical Disease 4: 181–184.
  • Colagiuri, R. 2010. Diabetes: A pandemic, a development issue or both? Expert Review of Cardiovascular Therapy 8: 305–309.
  • Colberg, S.R., Sigal, R.J., Fernhall, B., Regensteiner, J.D., Blissmer, B.J., Rubin, R.R., Chasan-Taber, L., Albright, A.N. & Braun, B. 2010. Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement. Diabetes Care 33: 2692–2696.
  • Day, C. & Bailey, C.J. 2011. Troglitazone. In xPharm: The Comprehensive Pharmacology Reference 1–3.
  • De Almeida, J.M., Theodoro, L.H., Nagata, M.J.H., Bonfante, S. & Garcia, V.G. 2008. Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes. The Journal of Periodontology 79: 2156–2165.
  • Derosa, G. & Maffioli, P. 2012. α-Glucosidase inhibitors and their use in clinical practice. Archives of Medical Science 8: 899–906.
  • Deutschländer, M.S., Lall, N., Van De Venter, M. & Hussein, A.A. 2011. Hypoglycaemic evaluation of a new triterpene and other compounds isolated from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark. Journal of Ethnopharmacology 133: 1091–1095.
  • Diamond, G.A., Bax, L. & Kaul, S. 2007. Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death. Annals of Internal Medicine 147: 578–581.
  • Dimo, T., Rakotonirina, S.V., Tan, P.V., Azay, E.D., Kamtchouing, P. & Cros, G. 2007. Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/methanol extract on streptozotocin-diabetic rats. Journal of Ethnopharmacology 110: 434–438.
  • Dinicolantonio, J.J., Bhutani, J. & O’keefe, J.H. 2015. Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart 2: e000327.
  • Domekouo, U.L., Longo, F., Tarkang, P.A., Tchinda, A.T., Tsabang, N., Donfagsiteli, N.T., Tamze, V., Kamtchouing, P. & Agbor, G.A. 2016. Evaluation of the antidiabetic and antioxidant properties of Morinda lucida stem bark extract in streptozotocin intoxicated rats. Pakistan Journal of Pharmaceutical Sciences 29: 903–911.
  • Duez, H., Cariou, B. & Staels, B. 2012. DPP-4 inhibitors in the treatment of type 2 diabetes. Biochemical Pharmacology 83: 823–832.
  • Eddouks, M. Bidi, A., El Bouhali., Hajji, L. & Zeggwagh, N.L. 2014. Antidiabetic plants improving insulin sensitivity. Journal of Pharmacy and Pharmacology 66: 1197–1214.
  • Edeoga, H.O., Okwu, D.E. & Mbaebie, B.O. 2005. Phytochemical constituents of some Nigerian medicinal plants. African Journal of Biotechnology 4: 685–688.
  • Erasto, P., Adebola, P.O., Grierson, D.S. & Afolayan, A.J. 2005. An ethnobotanical study of plants used for the treatment of diabetes in Eastern Cape Province, South Africa. African Journal of Biotechnology 4: 1458–1460.
  • Ezejiofor, A.N., Okorie, A. & Orisakwe, O.E. 2013. Hypoglycaemic and tissue protective effects of the aqueous extract of Persea Americana seeds on alloxan-induced albino rats. The Malaysian Journal of Medical Sciences 20(5): 31–39.
  • Feng, P.C. & Patrick, S.J. 1958. Studies of the action of hypoglycin-A, an hypoglycaemic substance. British Journal of Pharmacology and Chemotherapy 13: 125–130.
  • Foretz, M., Guigas, B., Betrand, L., Pollak, M. & Viollet, B. 2014. Metformin: from mechanisms of action to therapies. Cell Metabolism 20: 953–966.
  • Fuhlendorff, J., Rorsman, P., Kofod, H., Kofod, H., Brand, C.L., Rolin, B., Mackay, P., Shymko, R. & Carr, R.D. 1998. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47: 345–351.
  • Gallagher, A.M., Flatt, P.R., Duffy, G. & Abdel-Wahab, Y.H.A. 2003. The effects of traditional antidiabetic plants on in vitro glucose diffusion. Nutrition Research 23: 413–424.
  • Gelfand, M., Mavi, S., Drummond, R.B. & Ndemera, B., 1985. The Traditional Medical Practitioner in Zimbabwe: His principles of practice and pharmacopoeia. Gweru, Mambo Press.
  • George, C., Lochner, A. & Huisamen, B. 2011. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance. Journal of Ethnopharmacology 137: 298–304.
  • Godebo, A., Makonnen, E. & Mekonnen, N. 2017. Hypoglycaemic and antihyperglycemic effect of leaves extracts of Psidium guajava in normoglycemic and streptozotocin-induced diabetic mice. International Journal of Pharmacognosy 4: 250–256.
  • Grant, J.S. & Graven, L.J. 2016. Progressing from metformin to sulfonylureas or meglitinides. Workplace Health and Safety 64: 433–439.
  • Green, E.C. & Makhubu, L.P. 1984. Traditional healers in Swaziland: Towards improved cooperation between the traditional and modern health sectors. Social Science and Medicine 18: 1071–1079.
  • Groop, L.C. 1992. Sulfonylureas in NIDDM. Diabetes Care 15: 737–754.
  • Gruendel, S., Otto, B., Garcia, A.L., Wagner, K., Mueller, C., Weickert, M.O., Heldwein, W. & Koebnick, C. 2007. Carob pulp preparation rich in insoluble dietary fibre and polyphenols increases plasma glucose and serum insulin responses in combination with a glucose load in humans. The British Journal of Nutrition 98: 101–105.
  • Guardado-Mendoza, R., Prioletta, A., Jimenez-Ceja, L.M., Sosale, A. & Folli, F. 2013. The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus. Archives of Medical Science 9: 936–943.
  • Gumy, C., Thurnbichler, C., Aubry, E.M., Balazs, Z., Pfisterer, P., Baumgartner, L., Stuppner, H., Odermatt, A. & Rollinger, J.M. 2009. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines. Fitoterapia 80: 200–205.
  • Gundidza, M., Masuku, S., Humphrey, G. & Magwa, M.L. 2005. Anti-diabetic activity of Aloe excelsa. The Central African Journal of Medicine 51: 115–120.
  • Guo, J., Tongjun, L., Linna, H. & Yongmei, L. 2009. The effects of corn silk on glycaemic metabolism. Nutrition & Metabolism 6: 47.
  • Hamaty, M. 2011. Insulin treatment for type 2 diabetes: When to start, which to use. Cleveland Clinic Journal of Medicine 78: 332–342.
  • Hansen, A.M.K., Christensen., I.T. Hansen, J.B., Carr, R.D., Ashcroft, F.M. & Wahl, P. 2002. Differential interactions of nateglinide and repaglinide on the human β-cell sulphonylurea receptor 1. Diabetes 51: 2789–2795.
  • Hauner, H. 2002. The mode of action of thiazolidinediones. Diabetes/Metabolism Research and Reviews 18: suppl. 2.
  • Hawley, S.A., Gadalla, A.E., Olsen, G.S. & Hardie, D.G. 2002. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide independent mechanism. Diabetes 51: 2420–2425.
  • He, L. & Wondisford, F.E. 2015. Metformin action: Concentrations matter. Cell Metabolism 21: 159–162.
  • Hikino, H., Ishiyama, M., Suzuki, Y. & Konno, C. 1989. Mechanisms of hypoglycaemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Medica 55: 423–428.
  • Hill, R.S., Oberwetter, J.M. & Boyd, A.E. 1987. Increase in cAMP levels in beta-cell line potentiates insulin secretion without altering cytosolic free-calcium concentration. Diabetes 36: 440–446.
  • Howlett, H. & Bailey, C., 2007. Galegine and Antidiabetic Plants. Metformin: the gold standard. Chichester, John Wiley.
  • International Diabetes Federation (IDF). 2017. Latest IDF Africa News. https://www.idf.org/our-network/regions-members/africa/welcome.html (accessed 24 January 2018).
  • Inzucchi, S.E. & Mcguire, D.K. 2008. New drugs for the treatment of diabetes: part II: Incretin based therapy and beyond. Circulation 117: 574–584.
  • Islam, M.S. 2011. Effects of the aqueous extract of white tea (Camellia sinensis) in a streptozotocin-induced diabetes model of rats. Phytomedicine 19: 25–31.
  • Islam, M.S. & Choi, H., 2008. Effects of dietary onion (Allium cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. Annals of Nutrition and Metabolism 53: 6–12.
  • Karagiannis, T., Paschos, P., Paletas, K., Matthews, D.R. & Tsapas, A. 2012. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. Biomedical Journal 344: e1369.
  • Klopper, R.R., Chatelain, C., Banninger, V., Habashi, C., Steyn, H.M., De Wet, B.C., Arnold, T.H., Gautier, L., Smith, G.F. & Spichiger, R. 2006. Checklist of the flowering plants of Sub-Saharan Africa. An index of accepted names and synonyms. South African Botanical Diversity Network Report No. 42. Pretoria, SABONET.
  • Konaté, K., Yomalan, K., Sytar, O., Zerbo, P., Brestic, M., Patrick, V.D., Gagniuc, P. & Barro, N. 2014. Free radicals scavenging capacity, antidiabetic and antihypertensive activities of flavonoid-rich fractions from leaves of Trichilia emetica and Opilia amentacea in an animal model of type 2 diabetes mellitus. Evidence-Based Complementary and Alternative Medicine 2014: 867075.
  • Kumar, V., Prakash, O., Kumar, S. & Narwal, S. 2011. α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacognosy Reviews 5: 19–29.
  • Kumari, K. & Augusti, K.T. 2002. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats. Indian Journal of Experimental Biology 40: 1005–1009.
  • Lamos, E.L., Stein, S.A. & Davis, S.N. 2013. Sulfonylureas and meglitinides: Historical and contemporary issues. Panminerva Medica 55: 239–251.
  • Lanzotti, V. 2006. The analysis of onion and garlic. Journal of Chromatography A 1112: 3–22.
  • Loots, D.T., Pieters, M., Shahidul Islam, M. & Botes, L. 2011. Antidiabetic effects of Aloe ferox and Aloe greatheadii var. davyana leaf gel extracts in a low-dose streptozotocin diabetes rat model. South African Journal of Science 107: 46–51.
  • Mcgonigal, A. & Kapustin, J. 2008. Low-glycemic index diets: should they be recommended for diabetics? Journal for Nurse Practitioners 4: 688–696.
  • Mahomed, I.M. & Ojewole, J.A. 2003. Hypoglycaemic effect of Hypoxis hemerocallidea corm (African potato) aqueous extract in rats. Methods and Findings in Experimental and Clinical Pharmacology 25: 617–624.
  • Manyema, M., Veerman, J.L., Chola, L., Tugendhaft, A., Labadarios, D. & Hofman, K. 2015. Decreasing the burden of type 2 diabetes in South Africa: The impact of taxing sugar-sweetened beverages. PLoS ONE 10: 1–17.
  • Marles, R.J. & Farnsworth, N.R. 1995. Antidiabetic plants and their active constituents. Phytomedicine 2: 137–189.
  • Marquis, V.O., Adanlawo, T.A. & Olaniyi, A.A. 1977. The effect of foetidin from Momordica foetida on blood glucose level of albino rats. Planta Medica 31: 367–374.
  • Mathew, P.T. & Augusti, K.T. 1975. Hypoglycaemic effects of onion, Allium cepa Linn. on diabetes mellitus: a preliminary report. Indian Journal of Physiology and Pharmacology 19: 213–217.
  • Mdluli, K. 2002. Management of HIV/AIDS with traditional medicine. In L.P. Makhubu, O.O.G. Amusan & M.S. Shongwe (Eds), Proceedings of the Workshop on the Management of HIV/AIDS with Traditional Medicine, Kwaluseni, Swaziland.
  • Meier, J.J. 2012. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology 8: 728–742.
  • Meier, J.J. & Nauck, M.A. 2005. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes/Metabolism Research and Reviews 21: 91–117.
  • Melander, A., Lebovitz, H.E. & Faber, O.K. 1990. Sulfonylureas. Diabetes Care 13: 18–25.
  • Mencherini, T., Picerno, P., Del Gaudio, P., Festa, M., Capasso, A. & Aquino, R. 2010. Saponins and polyphenols from Fadogia ancylantha (Makoni Tea). Journal of Natural Products 73: 247–251.
  • Mizuno, C.S. Chittiboyina, A.G., Kurtz, T.W., Pershadsingh, H.A. & Avery, M.A. 2008. Type 2 diabetes and oral antihyperglycemic drugs. Current medicinal chemistry 15: 61–74.
  • Ministry of Health (MOH). 2010. National Health Strategic Plan 2011–2015: Towards Attainment of Health Related Millennium Development Goals. Ministry of Health.
  • Ministry of Health and Social Welfare (MOHSW). 2010. Lesotho. Ministry of Health and Social Welfare, Annual Joint Review Report (2009/10).
  • Mogale, M.A., Mkhombo, H.M., Lebelo, S.L., Shai, L.J., Chauke, M.A. & De Freitas, A. 2012. The effects of Clausena anisata (Wild) Hook leaf extracts on selected diabetic related metabolizing enzymes. Journal of Medicinal Plants Research 6: 4200–4207.
  • Mohammed, A., Ibrahim, M.A. & Islam, M.S. 2014. African medicinal plants with antidiabetic potentials . Planta Medica 80: 354–377.
  • Mooney, M.H., Fogarty, S., Stevenson, C., Gallagher, A.M., Palit, P., Hawley, S.A., Hardie, D.G., Coxon, G.D., Waigh, R.D., Tate, R.J., Harvey, A.L. & Furman, B.L. 2008. Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice. British Journal of Pharmacology 153: 1669–1677.
  • Motlhanka, D.M. & Makhabu, S.W. 2011. Medicinal and edible Wild fruit plants of Botswana as emerging new crop opportunities. Journal of Medicinal Plant Research 5: 1836–1842.
  • Motlhanka, D.M.T. & Nthoiwa, G.P. 2013. Ethnobotanical survey of medicinal plants of Tswapong North, in eastern Botswana: A case of plants from Mosweu and Seolwane villages. European Journal of Medicinal Plants 3(1): 10–24.
  • Moudi, M., Go, R., Yien, C.Y.S. & Nazre, M. 2013. Vinca alkaloids. International Journal of Preventive Medicine 4: 1131–1135.
  • Mousinho, N.M., Van Tonder, J.J. & Steenkamp, V. 2013. In vitro anti-diabetic activity of Sclerocarya birrea and Ziziphus mucronata. Natural Product Communication 8: 1279–1284.
  • Msyamboza, K.P., Ngwira, B., Dzowela, T., Mvula, C., Kathyola, D. & Harries, A.D. 2011. The burden of selected chronic non-communicable diseases and their risk factors in Malawi: Nationwide steps survey. PLoS ONE 6: 6–11.
  • Mukhtar, H.M., Ansari, S.H., Ali, M., Naved, T. & Bhat, Z.A. 2004. Effect of water extract of Psidium guajava on alloxan-induced diabetic rats. Pharmazie 59: 734–735.
  • Musabayane, C.T., Xozwa, K. & Ojewole, J.A. 2005. Effects of Hypoxis hemerocallidea corm (African Potato) aqueous extract on renal electrolyte and fluid handling in the rat. Renal Failure 27: 763–770.
  • Musabayane, C.T., Gondwe, M., Kamadyaapa, D.R., Moodley, K. & Ojewole, J.A.O. 2006. The effects of Sclerocarya birrea [Anacardiaceae] stem-bark aqueous extract on blood glucose, kidney and cardiovascular function in rats. Endocrine Abstracts 12: 36.
  • NHS. 2016. https://www.nhs.uk/conditions/diabetes-insipidus/causes/ (accessed 4 January 2019).
  • Nyirenda, K.K., Saka, J.D.K., Naidoo, D., Maharaj, V.J. & Muller, C.J.F. 2012. Antidiabetic, anti-oxidant and antimicrobial activities of Fadogia ancylantha extracts from Malawi. Journal of Ethnopharmacology 143: 372–376.
  • Odutuga, A.A., Dairo, J.O., Minari, J.B. & Bamisaye, F.A. 2010. Anti-diabetic effect of Morirtela lucida stem bark extracts on alloxan-induced diabetic rats. Research Journal of Pharmacology 4: 78–82.
  • Ojewole, J.A. 2003. Hypoglycaemic effect of Sclerocarya birrea stem bark aqueous extract in rats. Phytomedicine 10: 675–681.
  • Ojewole, J.A. 2004. Analgesic, anti-inflammatory and hypoglycaemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Methods and Findings in Experimental and Clinical Pharmacology 26: 409–416.
  • Ojewole, J.A. 2005. Hypoglycaemic and hypotensive effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract. Methods and Findings in Experimental and Clinical Pharmacology 27: 689–695.
  • Ojewole, J.A. 2006. Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea corm [‘African Potato’] aqueous extract in mice and rats. Journal of Ethnopharmacology 103: 126–134.
  • Ojewole, J.A. 2007. Analgesic, anti-inflammatory and hypoglycaemic effects of Rhus chirindensis stem-bark aqueous extract in mice and rats. Journal of Ethnopharmacology 113: 338–345.
  • Ojewole, J.A.O. 2008. Analgesic, anti-inflammatory and hypoglycaemic effects of Securidaca longepedunculata root-bark aqueous extract. Inflammopharmacology 16: 174–181.
  • Ojewole, J.A., Mawoza, T., Chiwororo, W.D.H. & Owira, P.M.O. 2010. Sclerocarya birrea (A. Rich) Hochst. [Marula] (Anacardiaceae): a review of its phytochemistry, pharmacology and toxicology and its ethnomedicinal uses. Phytotherapy Research 24: 633–639.
  • Olajide, O.A., Awe, S.O., Makinde, J.M. & Morebise, O. 1999. Evaluation of the anti-diabetic property of Morinda lucida leaves in streptozotocin-diabetic rats. Journal of Pharmacy and Pharmacology 51: 1321–1324.
  • Ong, K.W., Hsu, A., Song, L., Huang, D. & Tan, B.K.H. 2011. Polyphenols-rich Vernonia amygdalina shows anti-diabetic effects in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 133: 598–607.
  • Oyedemi, S.O., Bradley, G. & Afolayan, A.J. 2009. Ethnobotanical survey of medicinal plants used for the management of diabetes mellitus in the Nkonkobe municipality of South Africa. Journal of Medicinal Plants Research 3: 1040–1044.
  • Oyedemi, S.O., Adewusi, E.A., Aiyegoro, O.A. & Akinpelu, D.A. 2011. Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on streptozotocin-induced diabetic Wistar rats. Asian Pacific Journal of Tropical Biomedicine 1: 353–358.
  • Panten, U., Schwanstecher, M. & Schwanstecher, C. 1996. Sulfonylurea receptors and mechanism of sulfonylurea action. Experimental and Clinical Endocrinology & Diabetes 104: 1–9.
  • Parulkar, A.A., Pendergrass, M.L., Granda-Ayala, R., Lee, T.R. & Fonseca, V.A. 2001. Nonhypoglycaemic effects of thiazolidinediones. Annals of Internal Medicine 134: 61–71.
  • Patel, D.K., Prasad, S.K., Kumar, R. & Hemalatha, S. 2012. An overview on antidiabetic medicinal plants having insulin mimetics property. Asian Pacific Journal of Tropical Biomedicine 2(4): 320–330.
  • Peer, N., Kengne, A., Motala, A.A. & Mbanya., JC. 2014. Diabetes in the Africa region: 2013 update for the IDF diabetes Atlas. Diabetes Research & Clinical Practice. doi:10.1016/j.diabres.2013.11.006.
  • Petit, S. 2002. Species description. http://www.fao.org/ag (accessed 18 January 2018).
  • Phung, O.J., Sood, N.A., Sill, B.E. & Coleman, C.I. 2011. Oral anti-diabetic drugs for the prevention of Type 2 diabetes. Diabetic Medicine 28: 948–964.
  • Prasad-Reddy, L. & Isaacs, D. 2015. A clinical review of GLP-1 receptor agonists: Efficacy and safety in diabetes and beyond. Drugs in Context 4: 212283 doi:10.7573/dic.212283.
  • Qais, N., Jahan, S. & Shajib, M.S. 2018. A review on anti-diabetic plants. Dhaka University Journal of Pharmaceutical Sciences 17: 139–152.
  • Rios-Silva, M., Rtujillo, X., Trujillo-Hermandez, B., Sanchez-Pastor, E., Urzua, Z., Mancilla, E. & Huerta, M. 2014. Effect of chronic administration of forskolin on glycemia and oxidative stress in rats with and without experimental diabetes. International Journal of Medical science, 11, 448–452.
  • Rizos, C.V. & Elisaf, M.S. 2013. Metformin and cancer. European Journal of Pharmacology 705: 96–108.
  • Sabiu, S. & Ashafa, A.O.T. 2016. Membrane stabilization and kinetics of carbohydrate metabolizing enzymes (α-amylase and α-glucosidase) inhibitory potentials of Eucalyptus obliqua L.Her. (Myrtaceae) Blakely ethanolic leaf extract: An in vitro assessment. South African Journal of Botany 105: 264–269.
  • Sabiu, S., O’neill, F.H. & Ashafa, A.O.T. 2016. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment. Journal of Ethnopharmacology 183: 1–8.
  • Sabiu, S., Ajani, E.O., Sunmonu, T.O & Ashafa, A.O.T., 2017. Kinetics of modulatory role of Cyperus esculentus L. on the specific activity of key carbohydrate metabolizing enzymes. African Journal of Traditional Complementary and Alternative Medicine 14: 46–53.
  • Samuel, V.T. & Shulman, G.I. 2012. Mechanisms for insulin resistance: Common threads and missing links. Cell 148: 852–871.
  • Schoonjans, K. & Auwerx, J. 2000. Thiazolidinediones: an update. The Lancet 355: 1008–1010.
  • Scranton, R. & Cincotta, A. 2010. Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 11: 269–279.
  • Sheela, C.G., Kumud, K. & Augusti, K.T. 1995. Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats. Planta Medica 61: 356–357.
  • Sherratt, H.S.A. 1986. Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit. Trends in Pharmacological Sciences 7: 186–191.
  • Singh, S., Gupta, S.K., Sabir, G., Gupta, M.K. & Seth, P.K. 2009. A database for anti-diabetic plants with clinical/experimental trials. Bioinformation 4(6): 263–268.
  • Skillman, T.G. & Feldman, J.M. 1981. The pharmacology of sulfonylureas. The American Journal of Medicine 70: 361–372.
  • Snehlata, H.S. & Dande, P.R. 2012. Fenugreek (Trigonella foenum-graecum L.): An overview. International Journal of Current Pharmaceutical Review and Research 2: 170–187.
  • Snell, K. 1979. Alanine as a gluconeogenic carrier. Trends in Biochemical Sciences 4: 124–128.
  • Sonksen, P. & Sonksen. J. 2000. Insulin: Understanding its action in health and disease. British Journal of Anaesthesia 85: 69–79.
  • Sonne, D.P., Hansen M. & Knop, F.K. 2014. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion. European Journal of Endocrinology 171: 47–65.
  • Stephens, E. 2015. Insulin therapy in Type 1 diabetes. Medical Clinics of North America 99: 145–156.
  • Squadrito, F., Sturniolo, R., Trimarchi, G.R., Campo, G.M., De Luca, G.D., Gorini, A. & Caputi. A.P. 1990. Antihypertensive activity of indolepyruvic acid: A keto analogue of tryptophan. Journal of Cardiovascular Pharmacology 15: 102–108.
  • Stone, B. 1970. The flora of Guam: A manual for the identification of the vascular plants of the islands, with numerous photographs and line drawings. Micronesica 6: 454–455.
  • Teugwa, C.M., Mejiato, P.C., Zofou, D., Tchinda, B.T., & Boyom, F.F. 2013. Antioxidant and antidiabetic profiles of two African medicinal plants: Picralima nitida (Apocynaceae) and Sonchus oleraceus (Asteraceae) BMC Complementary Alternative Medicine, 13(1), 175
  • Thanigaivelan, K. & Muthukumaran, P. 2010. Antidiabetic effect of Psidium guajava leaves extract in alloxan induced diabetic rats. International Journal of Recent Scientific Research 5: 125–129.
  • Thring, T.S.A. & Weitz, F.M. 2006. Medicinal plant use in the Bredasdorp/Elim region of the Southern Overberg in theWestern Cape Province of South Africa. Journal of Ethnopharmacology 103: 261–275.
  • Tomoda, M., Shimizu, N., Gonda, R., Kanari, M., Yamada, H. & Hikino, H. 1990. Anti-complementary and hypoglycaemic activities of the glycans from the seeds of Malva Verticillata. Planta Medica 56: 168–170.
  • University Teaching Hospital 2010. University Teaching Hospital Action Plan 2009/2010: Health Management Information System. Lusaka, University Teaching Hospital.
  • Van De Venter, M., Roux, S., Bungu, L.C., Louw, J., Crouch, N.R., Grace, O.M., Maharaj, V., Pillay, P., Sewnarian, P., Bhagwandin, N. & Folb, P. 2008. Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. Journal of Ethnopharmacology 119: 81–86.
  • Van Wyk, B.E. 2008. A broad review of commercially important southern African medicinal plants. Journal of Ethnopharmacology 119: 342–355.
  • Van Wyk, B.-E. & Gericke, N. 2000. People’s Plants: A guide to useful plants of southern Africa. Pretoria, Briza.
  • Van Wyk, B.E. & Albrecht, C. 2008. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). Journal of Ethnopharmacology 119: 620–629.
  • Van Wyk, B.E., De Wet, H. & Van Heerden, F.R. 2008. An ethnobotanical survey of medicinal plants in the southeastern Karoo, South Africa. South African Journal of Botany 74: 696–704.
  • Van Wyk, B.E., Van Oudtshoorn, B. & Gericke, N. 1997. Medicinal plants of South Africa. Pretoria, Briza.
  • Viollet, B., Guigas, B., Garcia, N.S., LECLERC, J., Foretz, M. & Andreelli, F. 2012. Cellular and molecular mechanisms of metformin: an overview. Clinical Science (London) 122: 253–270.
  • Wang, B., Liu, H.C., Hong, J.R., Li, H.G., Huang, C.Y., Sichuan, DA., Xue, X., Bao, YI. & Xue, B. 2007. Effect of Psidium guajava leaf extract on alpha-glucosidase activity in small intestine of diabetic mouse. Journal of Sichuan University (Medical Science Edition) 38: 298–301.
  • Weiner, N. 1980. Drugs that inhibit adrenergic nerves and block adrenergic receptors. In A.G. Gilman, L.S. Goodman & A. Gilman (Eds), The Pharmacological Basis of Therapeutics 6th edn. New York,. Macmillian p. 176.
  • Wilcox, G. 2005. Insulin and insulin resistance. The Clinical Biochemist. Reviews/Australian Association of Clinical Biochemists 26: 19–39.
  • Wild, S., Roglic, G., Green, A., Sicree, R. & Hilary, K. 2004. Global prevalence of diabetes: estimates for the year 2000 and projection for 2030. Diabetes Care 27: 1047–1053.
  • Wink, M. 2008. Plant secondary metabolism: Diversity, function and its evolution. Natural Product Communications 3: 1205–1216.
  • World Health Organization (WHO) 2014. Non-communicable Diseases Country Profiles 2014 – UK. Geneva, World Health Organization.
  • World Health Organization (WHO). 2016. Global Report on Diabetes. Geneva, World Health Organization.
  • Yki-Järvinen, H. 2004. Thiazolidinediones. New England Journal of Medicine 351: 1106–1118.
  • Zhang, J., Hupfeld, C.J., Taylor, S.S., Olefsky, J.M. & Tsien, R.Y. 2005. Insulin disrupts β-adrenergic signalling to protein kinase A in adipocytes. Nature 437: 569–573.
  • Zibula, S.M.X. & Ojewole, J.A.O. 2000. Hypoglycaemic effects of Hypoxis hemerocallidea corm ‘African Potato’ methanolic extract in rats. Medical Journal of Islamic World Academy of Science 13: 75–78.
  • Zimmerman, B.R. 1997. Sulfonylureas. Endocrinology and Metabolism Clinics of North America 26: 511–522.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.